HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

JBIR-100

from Streptomyces; structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Lactones: 1549
  - Macrolides: 4391
    - JBIR-100: 1
  - Polyketides: 231
    - Macrolides: 4391
      - JBIR-100: 1
Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Polyketides: 231
    - Macrolides: 4391
      - JBIR-100: 1

Experts

1.	Bai, Li-Yuan: 1 article (07/2021)
2.	Chiu, Chang-Fang: 1 article (07/2021)
3.	Chiu, Shih-Jiuan: 1 article (07/2021)
4.	Feng, Chia-Hsien: 1 article (07/2021)
5.	Hu, Jing-Lan: 1 article (07/2021)
6.	Huang, Hao-Yu: 1 article (07/2021)
7.	Lin, Wei-Yu: 1 article (07/2021)
8.	Weng, Jing-Ru: 1 article (07/2021)

Related Diseases

1.

Breast Neoplasms (Breast Cancer)

07/01/2021 - "Cell growth was inhibited in response to JBIR-100 treatment concentration- and time-dependently in both MCF-7 and MDA-MB-231 breast cancer cells. "
07/01/2021 - "In summary, our results suggested that JBIR-100 may be potentially used for breast cancer therapy."
07/01/2021 - "In this study, the anti-proliferative effect of JBIR-100, a macrolide isolated from Streptomyces sp., was investigated in breast cancer cells. "

Related Drugs and Biologics

1.	Macrolides

Related Therapies and Procedures

1.	Therapeutics